Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toru Yamada

Showing results (101-110 of 146) with videos related to

Pageof 15
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 10, 2017
[A Case of Lung Adenocarcinoma Presenting with Leptomeningeal Carcinomatosis Successfully Treated with Afatinib after Erlotinib-Induced Hepatotoxicity]Hiroaki Tanaka, Minehiko Inomata, Ryuji Hayashi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 19, 2014
[Efficacy and toxicity of pemetrexed monotherapy for previously untreated elderly patients with non-squamous cell lung cancer with wild-type(or unknown)EGFR status]Minehiko Inomata, Ryuji Hayashi, Kotaro Tokui, et al.
Tumori|October 3, 2015
Lactate dehydrogenase and body mass index are prognostic factors in patients with recurrent small cell lung cancer receiving amrubicinMinehiko Inomata, Ryuji Hayashi, Kotaro Tokui, et al.
Cell|November 24, 2014
Neurons limit angiogenesis by titrating VEGF in retinaKeisuke Okabe, Sakiko Kobayashi, Toru Yamada, et al.
BMC Primary Care|July 7, 2023
Roles considered important for hospitalist and non-hospitalist generalist practice in Japan: a survey studyTaiju Miyagami, Taro Shimizu, Shunsuke Kosugi, et al.
Tumori|October 25, 2014
Outcome and prognostic factors in patients with small cell lung cancer who receive third-line chemotherapyMinehiko Inomata, Ryuji Hayashi, Kotaro Tokui, et al.
FEBS Letters|July 18, 2006
Ionizing radiation suppresses FAP-1 mRNA level in A549 cells via p53 activationToru Yamada, Muneharu Maruyama, Tadashi Fujita, et al.
Pathology Oncology Research : POR|September 21, 2018
Clinical Parameters for Predicting the Survival in Patients with Squamous and Non-squamous-cell NSCLC Receiving PD-1 Inhibitor TherapyMinehiko Inomata, Takahiro Hirai, Zenta Seto, et al.
Modern Rheumatology|October 10, 2006
Prevalence of Helicobacter pylori infection and risk of upper gastrointestinal ulcer in patients with rheumatoid arthritis in JapanEiichi Tanaka, Gurkirpal Singh, Akira Saito, et al.
Medical Oncology (Northwood, London, England)|August 11, 2014
Usefulness of the Palliative Prognostic Index in patients with lung cancerMinehiko Inomata, Ryuji Hayashi, Kotaro Tokui, et al.
Pageof 15

Showing results (101-110 of 146) with videos related to

Sort By:
Pageof 15
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 10, 2017
[A Case of Lung Adenocarcinoma Presenting with Leptomeningeal Carcinomatosis Successfully Treated with Afatinib after Erlotinib-Induced Hepatotoxicity]Hiroaki Tanaka, Minehiko Inomata, Ryuji Hayashi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 19, 2014
[Efficacy and toxicity of pemetrexed monotherapy for previously untreated elderly patients with non-squamous cell lung cancer with wild-type(or unknown)EGFR status]Minehiko Inomata, Ryuji Hayashi, Kotaro Tokui, et al.
Tumori|October 3, 2015
Lactate dehydrogenase and body mass index are prognostic factors in patients with recurrent small cell lung cancer receiving amrubicinMinehiko Inomata, Ryuji Hayashi, Kotaro Tokui, et al.
Cell|November 24, 2014
Neurons limit angiogenesis by titrating VEGF in retinaKeisuke Okabe, Sakiko Kobayashi, Toru Yamada, et al.
BMC Primary Care|July 7, 2023
Roles considered important for hospitalist and non-hospitalist generalist practice in Japan: a survey studyTaiju Miyagami, Taro Shimizu, Shunsuke Kosugi, et al.
Tumori|October 25, 2014
Outcome and prognostic factors in patients with small cell lung cancer who receive third-line chemotherapyMinehiko Inomata, Ryuji Hayashi, Kotaro Tokui, et al.
FEBS Letters|July 18, 2006
Ionizing radiation suppresses FAP-1 mRNA level in A549 cells via p53 activationToru Yamada, Muneharu Maruyama, Tadashi Fujita, et al.
Pathology Oncology Research : POR|September 21, 2018
Clinical Parameters for Predicting the Survival in Patients with Squamous and Non-squamous-cell NSCLC Receiving PD-1 Inhibitor TherapyMinehiko Inomata, Takahiro Hirai, Zenta Seto, et al.
Modern Rheumatology|October 10, 2006
Prevalence of Helicobacter pylori infection and risk of upper gastrointestinal ulcer in patients with rheumatoid arthritis in JapanEiichi Tanaka, Gurkirpal Singh, Akira Saito, et al.
Medical Oncology (Northwood, London, England)|August 11, 2014
Usefulness of the Palliative Prognostic Index in patients with lung cancerMinehiko Inomata, Ryuji Hayashi, Kotaro Tokui, et al.
Pageof 15